154 related articles for article (PubMed ID: 33617749)
1. Substance consumption and intoxication patterns in a medically supervised overdose prevention program for people experiencing homelessness.
Wishik G; Gaeta JM; Racine MW; O'Connell JJ; Baggett TP
Subst Abus; 2021; 42(4):851-857. PubMed ID: 33617749
[No Abstract] [Full Text] [Related]
2. Opioid-related overdose deaths among people experiencing homelessness, 2017 to 2021: A population-based analysis using coroner and health administrative data from Ontario, Canada.
Booth RG; Shariff SZ; Carter B; Hwang SW; Orkin AM; Forchuk C; Gomes T
Addiction; 2024 Feb; 119(2):334-344. PubMed ID: 37845790
[TBL] [Abstract][Full Text] [Related]
3. Drug Overdose Mortality Among People Experiencing Homelessness, 2003 to 2018.
Fine DR; Dickins KA; Adams LD; De Las Nueces D; Weinstock K; Wright J; Gaeta JM; Baggett TP
JAMA Netw Open; 2022 Jan; 5(1):e2142676. PubMed ID: 34994792
[TBL] [Abstract][Full Text] [Related]
4. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
5. Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA.
Paradise RK; Desmarais J; O'Malley SE; Hoyos-Cespedes A; Nurani A; Walley AY; Clarke J; Taylor S; Dooley D; Bazzi AR; Kimmel SD
Int J Drug Policy; 2023 Sep; 119():104127. PubMed ID: 37523844
[TBL] [Abstract][Full Text] [Related]
6. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder.
Magwood O; Salvalaggio G; Beder M; Kendall C; Kpade V; Daghmach W; Habonimana G; Marshall Z; Snyder E; O'Shea T; Lennox R; Hsu H; Tugwell P; Pottie K
PLoS One; 2020; 15(1):e0227298. PubMed ID: 31945092
[TBL] [Abstract][Full Text] [Related]
8. Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services.
Milaney K; Passi J; Zaretsky L; Liu T; O'Gorman CM; Hill L; Dutton D
Harm Reduct J; 2021 Aug; 18(1):92. PubMed ID: 34446034
[TBL] [Abstract][Full Text] [Related]
9. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs.
Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A
Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291
[TBL] [Abstract][Full Text] [Related]
11. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia.
Uzwiak BA; Hudgins A; Pizzicato LN
Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Homeless Adults Who Died of Drug Overdose: A Retrospective Record Review.
Bauer LK; Brody JK; León C; Baggett TP
J Health Care Poor Underserved; 2016; 27(2):846-59. PubMed ID: 27180712
[TBL] [Abstract][Full Text] [Related]
14. Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial.
Orkin A; Campbell D; Handford C; Hopkins S; Klaiman M; Leece P; Parsons JA; Shahin R; Strike C; Thorpe K; Sellen K; Milos G; Wright A; Charles M; Sniderman R; Morrison L;
BMJ Open; 2019 Nov; 9(11):e029436. PubMed ID: 31722937
[TBL] [Abstract][Full Text] [Related]
15. Sheltering risks: Implementation of harm reduction in homeless shelters during an overdose emergency.
Wallace B; Barber K; Pauly BB
Int J Drug Policy; 2018 Mar; 53():83-89. PubMed ID: 29289871
[TBL] [Abstract][Full Text] [Related]
16. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
[TBL] [Abstract][Full Text] [Related]
17. Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital.
Nolan S; Kelian S; Kerr T; Young S; Malmgren I; Ghafari C; Harrison S; Wood E; Lysyshyn M; Holliday E
Drug Alcohol Depend; 2022 Oct; 239():109608. PubMed ID: 36063622
[TBL] [Abstract][Full Text] [Related]
18. CAEP Position Statement: Emergency department management of people with opioid use disorder.
Koh JJ; Klaiman M; Miles I; Cook J; Kumar T; Sheikh H; Dong K; Orkin AM; Ali S; Shouldice E
CJEM; 2020 Nov; 22(6):768-771. PubMed ID: 33028446
[TBL] [Abstract][Full Text] [Related]
19. Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services.
Panagiotoglou D; Lim J
Int J Drug Policy; 2022 Dec; 110():103881. PubMed ID: 36274565
[TBL] [Abstract][Full Text] [Related]
20. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
